For investors looking at the hemp and cannabis sector in 2017, the most significant gains were concentrated among major Canadian growers and biopharmaceutical firms following pivotal partnerships and regulatory shifts. Top Performing Stocks of 2017
Analysts from Money Morning and Fox Business highlighted these firms for their clinical pipelines and diversified services: The 3 Best Marijuana Stocks of 2017 - The Motley Fool hemp stocks to buy 2017
: Stock price quadrupled (over 300% gain) following its expansion into CBD products and strategic supply deals. Biopharmaceutical & Industrial Stocks to Watch For investors looking at the hemp and cannabis
: Rallied 344% over the year, driven by a move to the larger TSX exchange and international supply agreements in Germany. Aphria : Gained 292% as a major Canadian medical producer. Aphria : Gained 292% as a major Canadian medical producer
According to reports from Yahoo Finance and The Motley Fool , these were the standout performers: